Role of Cbc Indices in Acute Lymphoblastic Leukemia Patients
ConditionLymphoblastic Leukemia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5-50
SponsorSohag University
About this trial
Role of cbc indices in acute lymphoblastic leukemia patients to explore the prognostic role of them in prediction the response to induction chemotherapy
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients newly diagnosed ALL
Disqualifiers
others malignanices
ALL on therapy
Trial design
Design model
Crossover
Treatments tested in this trial
complete blood count
Diagnostic testmeasure cbc and blood ratios to compare their values with respone of patients to treatment
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
neutrophil to lymphocyte ratio
count of neutophils comparing lymphocytees
Time frame
1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: